Cancer research
In a promising development for patients with estrogen receptor-positive (ER+)/HER2-negative (HER2-) metastatic breast cancer, elacestrant has been shown to significantly prolong progression-free survival (PFS) and improve clinical outcomes in patients who have not been treated with CDK4/6 inhibitors (CDK4/6i). The phase 3 EMERALD trial found that elacestrant
Cancer research
Researchers at Zunyi Medical University have made significant progress in the development of a novel combination therapy for treating non-small cell lung cancer (NSCLC). The study, published in Technology in Cancer Research & Treatment, investigated the efficacy and safety of combining anti-angiogenic agents, such as recombinant human vascular endothelial inhibitor
Prostate cancer
As news of President Joe Biden's stage 4 prostate cancer diagnosis and metastasis to his bones spread like wildfire, the world rallied around him with messages of support. However, his son Donald Trump Jr.'s reaction was scandalously different. He took to X (Twitter) to question Dr.
Prostate cancer
Astellas Pharma Inc. and Pfizer Inc. have announced longer-term follow-up results from an open-label extension of the Phase 3 ARCHES study, showing a significant improvement in overall survival benefits and a 30% reduction in the risk of death in men with metastatic hormone-sensitive prostate cancer (mHSPC) treated with XTANDI. These
Cancer research
A new study has shed light on the benefits of using whole-body magnetic resonance imaging (WB-MRI) in detecting metastatic sites and disease classification in patients with metastatic hormone-sensitive prostate cancer (mHSPC). Researchers at Portsmouth Hospitals University NHS Trust in the UK compared WB-MRI with computed tomography (CT) and bone scans
Cancer research
Researchers have made significant progress in the treatment of urothelial cancer, a common and often lethal disease. According to a new study, urothelial carcinoma, one of the most frequently diagnosed cancer types worldwide, has seen a turn in treatment with the introduction of immunotherapy. The study highlights the importance of
Cancer research
New research from the H. Lee Moffitt Cancer Center and Research Institute has demonstrated the effectiveness of radar-guided localization (RGL) in identifying and resecting metastatic melanoma lesions in patients who have undergone neoadjuvant immunotherapy (NEO). The study, published in the Annals of Surgical Oncology, found that RGL enabled accurate intraoperative
Cancer research
Researchers at Zhongnan Hospital of Wuhan University have made significant findings in the field of cancer gene therapy, shedding light on the potential biological target for treating hepatocellular carcinoma (HCC). The study, published in the Journal of Translational Medicine, highlights the crucial role of long non-coding RNA plasmacytoma variant translocation
Cancer research
Research from Soochow University in China has shed new light on the potential treatment of gastric cancer peritoneal metastasis. The study, supported by the National Natural Science Foundation of China, has identified PTBP3 as a key player in the development of gastric cancer. PTBP3, a splicing factor, is found to
Prostate cancer
President Donald Trump and his son Donald Trump Jr. drew ridicule after they appeared to confuse cancer stages in their comments on Joe Biden's prostate cancer diagnosis. Trump incorrectly stated that Biden has stage 9 cancer, and Trump Jr. tweeted about a 'stage 5' diagnosis, both
Prostate cancer
New research has identified several key risk factors for bone metastasis in patients with prostate cancer, including prostate-specific antigen (PSA), Gleason score, percentage of monocyte (M%), and N stage. The study, conducted by a team of researchers from Bengbu Medical University, analyzed data from 177 patients who had undergone radical
Prostate cancer
Former US President Joe Biden has been diagnosed with high-grade prostate cancer, according to an official statement released by his personal office. The statement announced that Biden was diagnosed with prostate cancer characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone, but the cancer
